• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
FinanceMarijuana

Marijuana Stocks Spike After Ex-House Speaker John Boehner Joins Cannabis Company Board

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
April 11, 2018, 11:48 AM ET

Former U.S. House Speaker John Boehner has done a 180 on weed, announcing Wednesday that he’s joining the advisory board of marijuana firm Acreage Holdings. The news was followed by notable spikes in prominent marijuana stocks.

Shares of the still-fledgling cannabis industry mainstays like Canada’s Aphria, Aurora, and others rose anywhere from 1% to more than 4% after Boehner’s surprise announcement, outpacing broader markets. Aurora Cannabis was up 2.5% in early Wednesday trading; the U.K.’s GW Pharmaceuticals, which is vying for the first Food and Drug Administration (FDA) approved cannabis-based medicine in the U.S., rose more than 2%; Canada’s MedReleaf spiked 4% while Aprhia had a more modest 1% rise.

Subscribe to Brainstorm Health Daily, our newsletter about the most exciting health innovations.

Boehner, a Republican ex-Congressman from Ohio, opposed marijuana legalization while he served in the House of Representatives before stepping down towards the end of 2015. But he cited an evolution in his thinking on Wednesday, reflecting a broader shift in how the public (and politicians) view marijuana decriminalization, legalization, and research. Boehner specifically cited the potential of medical marijuana to help stave off the opioid epidemic as a rationale for his changed thinking.

I’m joining the board of #AcreageHoldings because my thinking on cannabis has evolved. I’m convinced de-scheduling the drug is needed so we can do research, help our veterans, and reverse the opioid epidemic ravaging our communities. @AcreageCannabishttps://t.co/f5i9KcQD0W

— John Boehner (@SpeakerBoehner) April 11, 2018

“We need to look no further than our nation’s 20 million veterans, 20% of whom, according to a 2017 American Legion survey, reportedly use cannabis to self-treat PTSD, chronic pain, and other ailments,” said Boehner and former Massachusetts Governor Bill Weld, a libertarian who is also joining Acreage’s board of advisors. “Yet the [Department of Veterans Affairs] does not allow its doctors to recommend its usage. There are numerous other patient groups in America whose quality of life has been dramatically improved by the state-sanctioned use of medical cannabis.”

Acreage Holdings is an all-purpose marijuana company that handles operations such as cannabis cultivation, processing, and managing dispensaries. It’s a growth industry given that 30 states and the District of Columbia have broadly legalized the use of cannabis in some shape or form, and eight states, plus DC, have legalized recreational marijuana use outright.

This is Boehner’s second major foray into a “vice” industry—in the fall of 2016, Boehner (a notorious cigarette smoker) joined the board of tobacco giant Reynolds American, which makes popular cigarette brands like Camel, Newport, and Pall Mall.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Finance

EconomyFederal Reserve
Trump names Warsh, Hassett as top Fed contenders, WSJ says
By Jennifer A. Dlouhy and BloombergDecember 12, 2025
5 hours ago
EconomyFederal Reserve
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
8 hours ago
robots
InnovationRobots
‘The question is really just how long it will take’: Over 2,000 gather at Humanoids Summit to meet the robots who may take their jobs someday
By Matt O'Brien and The Associated PressDecember 12, 2025
8 hours ago
Man about to go into police vehicle
CryptoCryptocurrency
Judge tells notorious crypto scammer ‘you have been bitten by the crypto bug’ in handing down 15 year sentence 
By Carlos GarciaDecember 12, 2025
9 hours ago
Donald Trump, sitting in the Roosevelt Room, looks forward and frowns.
EconomyTariffs and trade
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
9 hours ago
Personal Financemortgages
7 best HELOC lenders in 2025: How to choose the best home equity line of credit for your situation
By Joseph HostetlerDecember 12, 2025
10 hours ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
18 hours ago
placeholder alt text
Success
At 18, doctors gave him three hours to live. He played video games from his hospital bed—and now, he’s built a $10 million-a-year video game studio
By Preston ForeDecember 10, 2025
3 days ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
14 hours ago
placeholder alt text
Success
Palantir cofounder calls elite college undergrads a ‘loser generation’ as data reveals rise in students seeking support for disabilities, like ADHD
By Preston ForeDecember 11, 2025
2 days ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
14 hours ago
placeholder alt text
Arts & Entertainment
'We're not just going to want to be fed AI slop for 16 hours a day': Analyst sees Disney/OpenAI deal as a dividing line in entertainment history
By Nick LichtenbergDecember 11, 2025
1 day ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.